Equities

Medpace Holdings Inc

Medpace Holdings Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)369.18
  • Today's Change7.89 / 2.18%
  • Shares traded1.00
  • 1 Year change+44.36%
  • Beta1.3551
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue1,8861,4601,142
OPERATING EXPENSES
Cost of revenue total1,3611,028814
Selling, general and admin. expenses, total161131108
Depreciation/amortization262221
Unusual expense(income)------
Other operating expenses, total------
Total operating expense1,5491,181944
Operating income337279199
Other, net1.273.210.56
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes336283202
Provision for income taxes533720
Net income after taxes283245182
Minority interest------
Net income before extra. Items283245182
Total extraordinary items------
Net income283245182
Inc.avail. to common excl. extra. Items283245181
Inc.avail. to common incl. extra. Items283245181
EPS RECONCILIATION
Basic/primary weighted average shares313236
Basic/primary eps excl. extra items9.207.575.06
Basic/primary eps incl. extra items9.207.575.06
Dilution adjustment------
Diluted weighted average shares323438
Diluted eps excl. extra items8.887.284.81
Diluted eps incl. extra items8.887.284.81
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock000
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental------
SUPPLEMENTAL INCOME
Depreciation, supplemental241916
Total special items------
NORMALISED INCOME
Normalized income before taxes336283202
Effect of special items on income taxes------
Income tax excluding impact of special items533720
Normalized income after tax283245182
Normalized income avail. to common283245181
Basic normalized EPS9.207.575.06
Diluted normalized EPS8.887.284.81
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.